Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.19 SEK 2.12% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Other Operating Expenses Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Other Operating Expenses
-kr2.8m
CAGR 3-Years
60%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Other Operating Expenses
kr348k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Operating Expenses
-kr11.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Other Operating Expenses
-kr4.3B
CAGR 3-Years
-469%
CAGR 5-Years
-221%
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Operating Expenses
kr16m
CAGR 3-Years
N/A
CAGR 5-Years
-19%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Other Operating Expenses
-kr81.7m
CAGR 3-Years
-17%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Vicore Pharma Holding AB's Other Operating Expenses?
Other Operating Expenses
-2.8m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Other Operating Expenses amounts to -2.8m SEK.

What is Vicore Pharma Holding AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
40%

Over the last year, the Other Operating Expenses growth was -57%. The average annual Other Operating Expenses growth rates for Vicore Pharma Holding AB have been 60% over the past three years , 40% over the past five years .

Back to Top